Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer releases new data for Pristiq

May 9, 2012
Research and Development, Sales and Marketing Effexor, MDD, Pfizer, Pristiq, antidepressant

Pfizer has released positive data for its established antidepressant Pristiq, as it hopes to extend the use of the drug.  …

News

The joy of segmentation

May 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Michael Craig, marketing, segmentation

We are all different. Different heights, shapes, hair colour and we are not just different physically – what about our …

Feature
Depakote image

Abbott pays $1.6 billion to settle Depakote claims

May 8, 2012
Medical Communications, Sales and Marketing AbbVie, Abbott, CIA, Depakote

Abbott will pay $1.6 billion to settle US legal claims over its epilepsy drug Depakote.  The $1.6 billion will settle …

News
Coughing woman image

UK government launches lung cancer awareness campaign

May 8, 2012
Medical Communications Cancer, UK, government, lung

The UK government has launched a new lung cancer awareness campaign backed by a number of celebrities.  Ricky Gervais and …

News

Auto Injectors: Addressing Proper Self-administration Needs with Training Devices

May 8, 2012
Manufacturing and Production

As the demand for biologics continues to increase, corresponding growth for advanced drug delivery devices such as auto injectors can …

Feature
Thought Leadership

Former Novartis man becomes GSK’s new medical director

May 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Shannon, Novartis

James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui.  He will be …

Appointment
Roche image

Roche abandons Phase III cholesterol drug

May 8, 2012
Medical Communications, Research and Development, Sales and Marketing CETP inhibitor, Roche, cardiovascular, dalcetrapib, phase III failure

Roche has abandoned its Phase III cholesterol treatment dalcetrapib after disappointing results.The manufacturer is ceasing work on the drug, once …

News

Teva launches first generic Lipitor in UK

May 8, 2012
Sales and Marketing Lipitor, NHS, Pfizer, Teva, atorvastatin

Teva has launched the first generic Lipitor in the UK on the day the drug loses its patent protection.  The …

News
Lucentis image

Novartis ponders Lucentis price cut in UK

May 8, 2012
Medical Communications, Sales and Marketing Lucentis, NICE, avastin, market access

 Novartis could cut the price of its eye drug Lucentis in the UK to head off moves to switch patients …

News
BASF image

BASF to build plant in US

May 8, 2012
Manufacturing and Production BASF, Taylor, manufacturing, production

BASF has said it plans to build a new manufacturing facility for formic acid at its production site in Louisiana, …

News

DSM sees green shoots for pharma unit in Q1

May 8, 2012
Business Services, Manufacturing and Production, Sales and Marketing DSM, Kensey Nash, NSCLC, Q1, Sinochem

DSM said its pharmaceutical business unit posted ‘weak’ financials in the first quarter of 2012, although revenues rose and there …

News
Genzyme image

Genzyme boosts capacity following green light for Waterford plant

May 8, 2012
Manufacturing and Production EMA, FDA, Genzyme, Sanofi, Waterford

Sanofi subsidiary Genzyme has doubled its capacity to fill-and-finish two of its drugs for rare disorders following approval of a …

News

ABPI to help pharma with digital communications

May 4, 2012
Medical Communications ABPI, Code breach, PMCPA, Shire, digital, pharma

The ABPI has set up a new group to help pharma with its online communications.  The UK industry body said …

News
GSK picture

GSK signs deal with academics

May 4, 2012
Research and Development, Sales and Marketing Cancer, GSK, PROTAC, Yale, academia

GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …

News

David Colin Thomé named as new Primary Care Commissioning chair

May 4, 2012
Business Services, Sales and Marketing NHS, PCC

Primary Care Commissioning (PCC) has appointed David Colin Thomé as chair with immediate effect.   Professor Thomé was until recently …

Appointment
Novartis image

Novartis to acquire Fougera for $1.5 billion

May 3, 2012
Sales and Marketing Fougera, Novartis, dermatology, generics, gilenya

Novartis will acquire the dermatology generics firm Fougera for $1.53 billion in cash.  Novartis’ generic unit Sandoz is conducting the …

News
Shell oil website

Roche and Novartis have best websites

May 3, 2012
Medical Communications Bowen Craggs & Co, Novartis, Pfizer, Roche, Shell, digital, web

A new survey of leading international companies has found Roche and Novartis have the best websites in the pharma sector.  …

News

GSK appoints two non-executive directors to its Board

May 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Jing Ulrich, Lynn Elsenhans

GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …

Appointment

Oxford BioTherapeutics appoints new chief operations officer

May 3, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics

Oxford BioTherapeutics (OBT) has appointed Dr Esteban Pombo-Villar as its new chief operations officer (COO). In this position he will …

Appointment

Pfizer enters Gaucher disease market

May 3, 2012
Sales and Marketing Cerezyme, Elelyso, Gaucher, Genzyme, Pfizer, Shire, Vpriv

Pfizer has gained FDA approval for its new Gaucher disease drug Elelyso.  Elelyso (taliglucerase alfa) is an enzyme replacement therapy …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026